Global Pharma Business Firm Strengthens Domestic Market Presence By Acquiring 100 Per cent Stake In Bombay Ortho Industries Through Subsidiary
Global Pharma Business Firm Strengthens Domestic Market Presence By Acquiring 100 Per cent Stake In Bombay Ortho Industries Through Subsidiary

Global Pharma Business Firm Strengthens Domestic Market Presence By Acquiring 100 Per cent Stake In Bombay Ortho Industries Through Subsidiary

In terms of performance, the stock has delivered a 1-year return of 4.69 per cent and a 3-year return of 45.08 per cent.

DSIJ Intelligence-2 Article rating: 5.0

In terms of performance, the stock has delivered a 1-year return of 4.69 per cent and a 3-year return of 45.08 per cent.

Recommendation from Banking Sector
Recommendation from Banking Sector

Recommendation from Banking Sector

Ratin Biswass Article rating: 5.0

This section gives a recommendation of a stock having stock price below Rs 150 with sound fundamentals and expected to give handsome returns over a one-year time horizon.

Recommendation from Chemical Sector
Recommendation from Chemical Sector

Recommendation from Chemical Sector

Ratin Biswass Article rating: 5.0

This column gives you scrip chosen by the research team during the fortnight that is fundamentally strong and expected to give good capital appreciation over a time period of 1 year.

Mutual Funds Pick Their Bets: Stocks Bought in March 2025
Mutual Funds Pick Their Bets: Stocks Bought in March 2025

Mutual Funds Pick Their Bets: Stocks Bought in March 2025

Despite a choppy market and declining inflows, mutual funds continued to bet on select large-cap, mid-cap, and small-cap stocks — here’s a look at what they bought.

DSIJ Intelligence Article rating: 5.0

Despite a choppy market and declining inflows, mutual funds continued to bet on select large-cap, mid-cap, and small-cap stocks — here’s a look at what they bought.

Rs 1,60,157 Crore Order Book: Heavy Electrical Equipment Company Signs Technology Transfer Agreement With Bhabha Atomic Research Centre
Rs 1,60,157 Crore Order Book: Heavy Electrical Equipment Company Signs Technology Transfer Agreement With Bhabha Atomic Research Centre

Rs 1,60,157 Crore Order Book: Heavy Electrical Equipment Company Signs Technology Transfer Agreement With Bhabha Atomic Research Centre

The President of India’s portfolio owns 63.17 per cent and Life Insurance Corporation of India’s portfolio owns 6.72 per cent as of March 2025.

DSIJ Intelligence-1 Article rating: 5.0

The President of India’s portfolio owns 63.17 per cent and Life Insurance Corporation of India’s portfolio owns 6.72 per cent as of March 2025.

Double Dhamaka! Board Likely To Announce Bonus Shares & Dividend; Stock Gave 16,680 Per Cent Multibagger Returns In Just 5 Years
Double Dhamaka! Board Likely To Announce Bonus Shares & Dividend; Stock Gave 16,680 Per Cent Multibagger Returns In Just 5 Years

Double Dhamaka! Board Likely To Announce Bonus Shares & Dividend; Stock Gave 16,680 Per Cent Multibagger Returns In Just 5 Years

The stock gave multibagger returns of 600 per cent in 2 years and a whopping 16,680 per cent in 5 years.

DSIJ Intelligence-1 Article rating: 4.3

The stock gave multibagger returns of 600 per cent in 2 years and a whopping 16,680 per cent in 5 years.

DSIJ MINDSHARE

Mkt Commentary17-Apr, 2025

Mindshare17-Apr, 2025

Mutual Fund17-Apr, 2025

Mindshare17-Apr, 2025

Penny Stocks17-Apr, 2025

Knowledge

General22-Mar, 2025

MF14-Mar, 2025

MF14-Mar, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR